Visit
|
CEA
|
CAS
|
BMT
|
total
|
p1
|
p2
|
---|
Screening□
|
80.3% (163)
|
73.6% (145)
|
78.8% (89)
|
77.4% (397)
|
0.257⌐
| |
D30
|
87.6% (163)
|
86.7% (156)
|
91.5% (97)
|
88.1% (416)
|
0.456⌐
|
< 0.0001^*
|
M6
|
91.7% (166)
|
86.9% (152)
|
93.5% (101)
|
90.3% (419)
|
0.131⌐
|
< 0.0001^*
|
A1
|
92.5% (160)
|
87.6% (149)
|
93.2% (96)
|
90.8% (405)
|
0.190⌐
|
< 0.0001^*
|
- *Significant
- ⌐Chi2-test
- ^McNemar test
- □Already published [23]; D30: Visit 30 days after screening visit; M6: Visit 6 months after screening visit; A1: Visit o ne year after screening visit
- 1testing CEA vs. CAS vs. BMT
- 2testing rate of statin medication on D30/M6/A1 vs. screening visit